Abstract Details
|
David Landzberg, MD
PRESENTER |
Dr. Landzberg has nothing to disclose. |
| No disclosure on file | |
| Isaiah Rolle, DO, PhD | Dr. Rolle has nothing to disclose. |
| Mahmoud H. Mohammaden, MD (Emory University School of Medicine) | Dr. Mohammaden has nothing to disclose. |
| Raul G. Nogueira, MD (UPMC Stroke Institute) | Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus. |
| Srikant Rangaraju, MBBS (Emory University, Atlanta) | Dr. Rangaraju has nothing to disclose. |
| Fadi B. Nahab, MD | Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care. |
| Dinesh V. Jillella, MD (Emory University School of Medicine / Grady Memorial Hospital) | Dr. Jillella has nothing to disclose. |